Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Cellectar Biosciences Inc
CLRB
Healthcare
Biotechnology
Cellectar Biosciences, Inc. is a late-stage clinical biopharmaceutical company. The Company is focused on the discovery, development and commercialization of drugs for the treatment of cancer. The Company, through phospholipid ether drug conjugate (PDC) delivery platform, is focused on developing PDCs that are designed to specifically target cancer cells. Its PDC platform possesses the...
potential for the discovery and development of cancer-targeting treatments, and it plans to develop PDCs both independently and through research and development collaborations. Its product pipeline includes iopofosine, a small-molecule PDC designed to provide targeted delivery of iodine-131 (radioisotope), preclinical PDC chemotherapeutic programs and multiple partnered PDC assets. Its Iopofosine is evaluated in the completed CLOVER-WaM Phase 2 pivotal study in patients with relapsed/refractory (r/r) Waldenstrom’s macroglobulinemia (WM).
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:CLRB)
New Post
View:
Posts & Comments
Threaded Posts
(3)
•••
mattusvi
X
View Profile
View Bullboard History
Post by
mattusvi
on Jul 30, 2020 8:14am
CLRB up in PM with Volume
Cellectar Biosciences (CLRB) Using its patented phospholipid drug conjugates (PDCs) delivery platform to specifically target cancer cells, Cellectar Biosciences wants to improve the lives of
...more
(2)
•••
aee
X
View Profile
View Bullboard History
Post by
aee
on Jan 21, 2019 2:50pm
FDA Import Alert
For the record, the FDA Import Alert stopping CLR131 imports from CPDC can be found at https://www.accessdata.fda.gov/cms_ia/importalert_189.html CLRB has a exception for hematology
...more
(0)
•••
RICHGUN
X
View Profile
View Bullboard History
Post by
RICHGUN
on Feb 17, 2017 12:19pm
Huge discrepancy in warrant pricing
I cannot believe that the warrants are trading at these prices CLRBZ $.66 CLRBW $.40 The CLRBZ warrants have an exercise price of $3.04 and an expiration date of April 20, 2021. The CLRBW warrants
...more
(0)
•••
RICHGUN
X
View Profile
View Bullboard History
Post by
RICHGUN
on Feb 16, 2017 11:31pm
Correction on clrb warrants
I am awfully sorry if I have misled anyone on these warrants I have received an email from the company as quoted below The CLRBZ warrants have an exercise price of $3.04 and an expiration date
...more
(0)
•••
RICHGUN
X
View Profile
View Bullboard History
Post by
RICHGUN
on Feb 14, 2017 9:29pm
The warrants are a steal Only $.70 from the $3.04 strike
Make sure you get the Z warrants clrbz. The potential for this company is excellent and the warrants are way below value I could see an acquisition or take out on this company at $22 - $25
...more
(0)
•••
RICHGUN
X
View Profile
View Bullboard History
Post by
RICHGUN
on Feb 13, 2017 12:27am
Something going down?
There is something very strange going on here when you see the clrbw warrants trading up 150% on four times the volume when they're basically worthless. I have gone long on the CLRBz
...more
(0)
•••
RICHGUN
X
View Profile
View Bullboard History
Post by
RICHGUN
on Feb 11, 2017 12:40am
CLRBW warrants VS. CLRBZ warrants
The clrbw warrants traded up from .18 to $.45 today which means that you are paying $4.50 for the right to buy one share because you need 10 warrants to buy one share at 10 x $4.68 (
...more
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Meet one of the Strongest Contenders to Lead Canada’s Cannabis Market
Multiple High-Grade Gold Hits at the Tonopah Gold Project Including 90 Meters at 2.0 gpt Gold
An Opportunity to Join Pulsar Helium on the Ground in Minnesota for a Historic Reservoir Flow Test
NOI Filed for Drill Program at Lithium/Uranium Project in Nevada
Silvercorp to Acquire Adventus for Implied Consideration of C$0.50 per Share